Characteristics of included cohorts (N = 115)
| ∗Mid-year of observation | 2009 (2000-2014) |
| Years of follow-up | 2.9 (1.8-4.4) |
| Age range (y), n (%) | |
| Adults only (≥18) | 33 (29) |
| Adults and adolescents (≥13) | 18 (16) |
| Adults and children | 61 (53) |
| Not reported | 3 (3) |
| Participant age, y | 30 (28-34) |
| Sample size, n | 94 (50-196) |
| Male sex, % | 60 (53-68) |
| Stage III/IV, % | 57 (44-71) |
| B symptoms, % | 58 (43-70) |
| ∗Mid-year of observation | 2009 (2000-2014) |
| Years of follow-up | 2.9 (1.8-4.4) |
| Age range (y), n (%) | |
| Adults only (≥18) | 33 (29) |
| Adults and adolescents (≥13) | 18 (16) |
| Adults and children | 61 (53) |
| Not reported | 3 (3) |
| Participant age, y | 30 (28-34) |
| Sample size, n | 94 (50-196) |
| Male sex, % | 60 (53-68) |
| Stage III/IV, % | 57 (44-71) |
| B symptoms, % | 58 (43-70) |
All data are shown as median (IQR) unless otherwise indicated.
Defined as the midpoint between study data collection start and end year.